Licorice Versus Sugar-water Gargling for Pain in Patients Recovering From Ear-Nose-Throat and Maxilla-Facial Surgery
1 other identifier
interventional
127
1 country
1
Brief Summary
Our primary aim is to determine whether licorice gargling provides meaningful analgesia after oral surgery. Specifically, we propose to test the primary hypothesis that gargling with licorice solution reduces pain after oral surgery more than gargling with sugar water. Because effective analgesia can reduce pain and/or opioid consumption, we will jointly evaluate verbal response pain scores and overall morphine consumption considering licorice to be beneficial only if it proves non-inferior on both measures and superior on at least one.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 14, 2016
CompletedFirst Posted
Study publicly available on registry
November 21, 2016
CompletedStudy Start
First participant enrolled
July 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2022
CompletedSeptember 5, 2023
August 1, 2023
5.3 years
November 14, 2016
August 30, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
joint - pain scores and opiate consumption in Post Anesthesia Care Unit (PACU)
A joint outcome of average pain score and total opioid consumption between the end of surgery and the first two postoperative hours. Joint hypothesis testing will be used, meaning that Licorice gargling will be deemed better than sugar-water only if found noninferior on both opioid consumption and pain score and superior on at least one of the two.
first 2 postoperative hours
Secondary Outcomes (3)
joint - pain scores and opiate consumption on day of surgery
from end of surgery until the morning of Post-Operative Day (POD) 1
joint - pain scores and analgesic consumption
from surgery conclusion to Post-Operative Day (POD) 3
postoperative coughing
first 2 postoperative hours
Study Arms (2)
Licorice
ACTIVE COMPARATORLicorice gargle
Sugar water
PLACEBO COMPARATORSugar gargle
Interventions
ExtractumLiquiritiaeFluidum, 1 g diluted in 30cc water, gargle the solution for 60 seconds without swallowing it starting preoperatively, 3 times a day until post-operative day 3
Sugar gargle: Sirupus Simplex (sugar 5 g) diluted in 30cc water, gargle the solution for 60 seconds without swallowing it starting preoperatively, 3 times a day until post-operative day 3
Eligibility Criteria
You may qualify if:
- Oropharyngeal surgeries including:Panendoscopic surgery; elective tonsillectomy/adenotonsillectomy; demarcation and biopsy of suspected tongue carcinoma
- Anticipated extubation in the operating room
- American Society of Anesthesia physical status 1-3
You may not qualify if:
- Rapid Sequence Induction
- Known or suspected allergy to licorice or its ingredients
- Liver failure with bleeding disorders
- Insulin-dependent diabetes mellitus
- Use of non-steroidal anti-inflammatory drug medication within 24 hours before surgery
- Chronic opioid use
- Dementia or inability to use an iv Patient-Controlled-Analgesia (PCA) pump
- superinfected oropharyngeal tumors
- Planned postoperative mechanical ventilation or admission to Intensive Care Unit (ICU)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medical University of Viennalead
- The Cleveland Cliniccollaborator
Study Sites (1)
MUVienna
Vienna, Austria
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Olga Plattner, M.D.
Medical University of Vienna
- PRINCIPAL INVESTIGATOR
Marita Windpassinger, M.D.
Medical University Vienna
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ao. Univ. Prof., Head of ophthalmologic anesthesia
Study Record Dates
First Submitted
November 14, 2016
First Posted
November 21, 2016
Study Start
July 1, 2017
Primary Completion
September 30, 2022
Study Completion
September 30, 2022
Last Updated
September 5, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share